[go: up one dir, main page]

ES545558A0 - Un procedimiento para la preparacion de un derivado de glu- tarimida - Google Patents

Un procedimiento para la preparacion de un derivado de glu- tarimida

Info

Publication number
ES545558A0
ES545558A0 ES545558A ES545558A ES545558A0 ES 545558 A0 ES545558 A0 ES 545558A0 ES 545558 A ES545558 A ES 545558A ES 545558 A ES545558 A ES 545558A ES 545558 A0 ES545558 A0 ES 545558A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
glutarimide derivative
glutarimide
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545558A
Other languages
English (en)
Other versions
ES8604151A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of ES8604151A1 publication Critical patent/ES8604151A1/es
Publication of ES545558A0 publication Critical patent/ES545558A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
ES545558A 1984-07-30 1985-07-24 Un procedimiento para la preparacion de un derivado de glu- tarimida Expired ES8604151A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63539484A 1984-07-30 1984-07-30

Publications (2)

Publication Number Publication Date
ES8604151A1 ES8604151A1 (es) 1986-01-16
ES545558A0 true ES545558A0 (es) 1986-01-16

Family

ID=24547629

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545558A Expired ES8604151A1 (es) 1984-07-30 1985-07-24 Un procedimiento para la preparacion de un derivado de glu- tarimida

Country Status (19)

Country Link
EP (1) EP0170213B1 (es)
JP (1) JPH0631222B2 (es)
KR (1) KR880002625B1 (es)
AR (1) AR241161A1 (es)
AT (1) ATE49409T1 (es)
AU (1) AU578962B2 (es)
CA (1) CA1244418A (es)
DE (1) DE3575301D1 (es)
DK (1) DK163304C (es)
ES (1) ES8604151A1 (es)
FI (1) FI84178C (es)
GR (1) GR851835B (es)
HU (1) HU197002B (es)
IE (1) IE58073B1 (es)
IL (1) IL75901A (es)
NO (1) NO159089C (es)
NZ (1) NZ212856A (es)
PT (1) PT80859B (es)
ZA (1) ZA855563B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704389A (en) * 1986-03-05 1987-11-03 Merrell Dow Pharmaceuticals Inc. Aromatic omega-alkyl-imino-tetrahydro-6H-1,3-thiazin-6-one derivatives
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
US4696927A (en) * 1986-03-05 1987-09-29 Merrell Dow Pharmaceuticals Inc. 4-(2-pyrimidinyl)-1-piperazinyl heterocyclic carbonyl derivatives
PH25227A (en) * 1986-03-05 1991-03-27 Merrell Dow France Et Co Aromatic w-alkylamino-tetrahydro-6h-1,3-thiazin-6-one derivatives, pharmaceutical composition containing same and method of use thereof
US5158956A (en) * 1990-05-04 1992-10-27 Eli Lilly And Company Method of inhibiting gastric acid secretion with benzodioxanes
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
JPH06504279A (ja) * 1990-12-24 1994-05-19 メレルダウファーマス−ティカルズ インコーポレイテッド 欝病及び躁病の治療におけるある種のグルタルイミド誘導体の用途
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
WO1992020338A1 (en) * 1991-05-10 1992-11-26 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
US5189171A (en) * 1991-06-21 1993-02-23 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5182292A (en) * 1991-06-21 1993-01-26 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5134140A (en) * 1991-06-21 1992-07-28 American Home Products Corporation Psychotropic benzofuran derivatives
US5166367A (en) * 1991-06-21 1992-11-24 American Home Products Corporation Antipsychotic benzodioxan derivatives
US5126367A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Psychotropic benzodioxan derivatives
US5221745A (en) * 1991-06-21 1993-06-22 American Home Products Corp. Psychotropic piperidinylmethyl benzodioxans
US5212170A (en) * 1991-06-21 1993-05-18 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5126366A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Aminophenoxyalkyl derivatives of benzodioxan
FR2678617B1 (fr) * 1991-07-01 1995-01-20 Adir Nouveau procede de synthese d'enantiomeres de derives du 3-amino chromane.
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
JP3136206B2 (ja) * 1991-10-22 2001-02-19 中外製薬株式会社 ベンゾジオキサン誘導体
CA2090767A1 (en) * 1992-03-06 1993-09-07 Gerald Guillaumet 1,4-dioxino[2,3-b]pyridine derivatives
US5235055A (en) * 1992-09-02 1993-08-10 American Home Products Corporation Antipsychotic quinoline derivatives of benzodioxanmethylamine
US5245051A (en) * 1992-09-03 1993-09-14 American Home Products Corporation Antipsychotic chroman derivatives of benzodioxanmethylamine
GB9305672D0 (en) * 1993-03-19 1993-05-05 Wyeth John & Brother Ltd Amide derivatives
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
WO2005110984A1 (ja) * 2004-05-17 2005-11-24 Daicel Chemical Industries, Ltd. N−ヒドロキシ環状イミド化合物の製造法
JP2011507835A (ja) 2007-12-21 2011-03-10 アンドレイ・アレクサンドロビッチ・イワシェンコ α−アドレナリン受容体、ドーパミン、ヒスタミン、イミダゾリン及びセロトニン受容体のリガンド並びにその使用
KR102022154B1 (ko) * 2016-11-24 2019-09-18 한양대학교 산학협력단 MBD2-p66α(GATAD2A)의 상호작용을 억제하는 화합물을 포함하는 암 전이 억제 및 암 질환 예방 및 치료용 조성물

Also Published As

Publication number Publication date
DK344085D0 (da) 1985-07-29
FI84178C (fi) 1991-10-25
NO159089C (no) 1988-11-30
IE58073B1 (en) 1993-06-30
PT80859A (en) 1985-08-01
AU4535385A (en) 1986-02-06
HU197002B (en) 1989-02-28
JPS61246180A (ja) 1986-11-01
IL75901A0 (en) 1985-12-31
PT80859B (pt) 1987-09-18
NO159089B (no) 1988-08-22
KR860001103A (ko) 1986-02-22
DE3575301D1 (de) 1990-02-15
ES8604151A1 (es) 1986-01-16
FI852922L (fi) 1986-01-31
AU578962B2 (en) 1988-11-10
CA1244418A (en) 1988-11-08
FI852922A0 (fi) 1985-07-26
DK163304B (da) 1992-02-17
EP0170213A1 (en) 1986-02-05
AR241161A1 (es) 1991-12-30
DK163304C (da) 1992-07-06
EP0170213B1 (en) 1990-01-10
JPH0631222B2 (ja) 1994-04-27
IL75901A (en) 1988-11-15
FI84178B (fi) 1991-07-15
GR851835B (es) 1985-12-02
NO852994L (no) 1986-01-31
AR241161A2 (es) 1991-12-30
KR880002625B1 (ko) 1988-12-07
HUT38338A (en) 1986-05-28
NZ212856A (en) 1988-05-30
ZA855563B (en) 1986-05-28
ATE49409T1 (de) 1990-01-15
DK344085A (da) 1986-01-31
IE851870L (en) 1986-01-30

Similar Documents

Publication Publication Date Title
ES545558A0 (es) Un procedimiento para la preparacion de un derivado de glu- tarimida
ES548430A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbazolona
ES552047A0 (es) Un procedimiento para la preparacion de derivados de indol
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES539281A0 (es) Un procedimiento para la preparacion de derivados de piperidina.
ES548671A0 (es) Un procedimiento para la preparacion de un derivado de dihi-dropiridina
ES557126A0 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
ES543078A0 (es) Un procedimiento para la preparacion de un derivado de indo-lina o de 2-indolinona
ES539954A0 (es) Procedimiento de preparacion de un derivado de ciano-2-ben- cimidazol
ES554609A0 (es) Un procedimiento para la preparacion de derivados de oxindol
ES548033A0 (es) Un procedimiento para la preparacion de nuevos derivados pe-nem
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES544970A0 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES551755A0 (es) Un procedimiento para la preparacion de derivados de d4-y-d5-androsteno nuevos
ES552402A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ES548960A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES557267A0 (es) Un procedimiento para la preparacion de derivados amidinofenilicos
ES548147A0 (es) Un procedimiento para la preparacion de nuevos derivados pe-nem
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
ES544214A0 (es) Un procedimiento para la preparacion de un derivado de n-metil-1-alquiltio-2-nitroetonamina
ES553605A0 (es) Un procedimiento para la preparacion de derivados de carbpenem
ES552986A0 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas
ES542674A0 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina
ES542366A0 (es) "un procedimiento para la preparacion de un derivado de ce- falosporina"
ES551817A0 (es) Un procedimiento para la preparacion de derivados de dihidropiridina